Arizona State Retirement System’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $682K | Buy |
31,639
+631
| +2% | +$13.6K | ﹤0.01% | 1300 |
|
2025
Q1 | $515K | Sell |
31,008
-265
| -0.8% | -$4.4K | ﹤0.01% | 1403 |
|
2024
Q4 | $574K | Buy |
31,273
+433
| +1% | +$7.95K | ﹤0.01% | 1420 |
|
2024
Q3 | $474K | Buy |
30,840
+857
| +3% | +$13.2K | ﹤0.01% | 1513 |
|
2024
Q2 | $487K | Buy |
29,983
+655
| +2% | +$10.6K | ﹤0.01% | 1450 |
|
2024
Q1 | $542K | Sell |
29,328
-423
| -1% | -$7.82K | ﹤0.01% | 1396 |
|
2023
Q4 | $932K | Sell |
29,751
-348
| -1% | -$10.9K | 0.01% | 1079 |
|
2023
Q3 | $627K | Sell |
30,099
-1,798
| -6% | -$37.5K | 0.01% | 1251 |
|
2023
Q2 | $764K | Sell |
31,897
-3,293
| -9% | -$78.9K | 0.01% | 1172 |
|
2023
Q1 | $662K | Buy |
35,190
+939
| +3% | +$17.7K | 0.01% | 1249 |
|
2022
Q4 | $545K | Buy |
34,251
+1,350
| +4% | +$21.5K | 0.01% | 1320 |
|
2022
Q3 | $538K | Buy |
32,901
+227
| +0.7% | +$3.71K | 0.01% | 1285 |
|
2022
Q2 | $460K | Buy |
32,674
+83
| +0.3% | +$1.17K | ﹤0.01% | 1407 |
|
2022
Q1 | $789K | Buy |
32,591
+164
| +0.5% | +$3.97K | 0.01% | 1194 |
|
2021
Q4 | $757K | Sell |
32,427
-297
| -0.9% | -$6.93K | 0.01% | 1281 |
|
2021
Q3 | $544K | Buy |
32,724
+95
| +0.3% | +$1.58K | ﹤0.01% | 1494 |
|
2021
Q2 | $796K | Sell |
32,629
-2,080
| -6% | -$50.7K | 0.01% | 1262 |
|
2021
Q1 | $895K | Buy |
34,709
+158
| +0.5% | +$4.07K | 0.01% | 1199 |
|
2020
Q4 | $1.85M | Sell |
34,551
-719
| -2% | -$38.4K | 0.02% | 723 |
|
2020
Q3 | $1.46M | Buy |
35,270
+8,974
| +34% | +$370K | 0.01% | 743 |
|
2020
Q2 | $1.28M | Sell |
26,296
-824
| -3% | -$40K | 0.02% | 654 |
|
2020
Q1 | $1.15M | Buy |
+27,120
| New | +$1.15M | 0.02% | 623 |
|